Biocerta Precision Diagnostics
Biocerta Precision Diagnostics seeks to replace the one-size-fits-all approach to cancer treatment with precision.
/
Challenge
(01)
The Right Treatment Faster
Biocerta Precision Diagnostics seeks to replace the one-size-fits-all approach to cancer treatment with precision. Their CertaPath DST platform tests a patient's tumor against 200+ chemotherapy agents, giving oncologists clear, personalized data to select the right treatment faster and with greater confidence.
More Portfolio Companies
A curated selection of projects that reflect our commitment to simplicity and purposeful design.
Biocerta Precision Diagnostics
Biocerta Precision Diagnostics seeks to replace the one-size-fits-all approach to cancer treatment with precision.
/
Challenge
(01)
The Right Treatment Faster
Biocerta Precision Diagnostics seeks to replace the one-size-fits-all approach to cancer treatment with precision. Their CertaPath DST platform tests a patient's tumor against 200+ chemotherapy agents, giving oncologists clear, personalized data to select the right treatment faster and with greater confidence.
More Companies We Help
A curated selection of projects that reflect our commitment to simplicity and purposeful design.
Biocerta Precision Diagnostics
Biocerta Precision Diagnostics seeks to replace the one-size-fits-all approach to cancer treatment with precision.
/
About the company
(01)
The Right Treatment Faster
Biocerta Precision Diagnostics seeks to replace the one-size-fits-all approach to cancer treatment with precision. Their CertaPath DST platform tests a patient's tumor against 200+ chemotherapy agents, giving oncologists clear, personalized data to select the right treatment faster and with greater confidence.